mark cuban pharmacy semaglutide Cuban's Cost Plus partners with telehealth firm to offer employers obesity care drugs Mark Cuban has compelling words

Liraglutide, sold under many brand names, including Saxenda, is a prescription-only weight loss medication explicitly approved for weight management, particularly for those who suffer from weight-related symptoms, such as type 2 diabetes

Summary: Retatrutide FDA Status Retatrutide is not FDA-approved and won't be for at least another year It's in Phase 3 trials (TRIUMPH program) with results expected in late 2026 FDA approval is projected for 20272028 Phase 2 data showed 24.2% weight loss , better than any approved GLP-1 medication Current access: clinical trials (free), compounded retatrutide ($200$500/mo), or research peptides ($150$500/mo) When approved, retatrutide will be the first triple-agonist obesity medication on the market References Jastreboff AM, Aronne LJ, Ahmad NN, et al

Great post, Stuart Phillips

adults are classified as being either obese or overweight

While some labs study a dsip peptide nasal spray to review alternative absorption pathways, raw lyophilized powders remain the global laboratory standard for precise analytical dosing and variable isolation

This is a safer approach because your body's natural feedback system stays intact